UK - MASA and Midven invest £600,000 into Cytox
MASA Life Sciences and Midven have completed a £600,000 seed investment into neuroscience company Cytox Limited, alongside existing investors, management and US-based business angel Dr. Jim Foght, who joins the company as advisor.
Birmingham-based Cytox develops products and services for neurodegenerative disorders. The company provides biomarker services to pharmaceutical industry clients, conducting clinical trials with drugs for the treatment of Alzheimer's disease (AD) and mild cognitive impairment (MCI). Cytox's tests require a single blood draw from patients, which is significantly less invasive than tests requiring cerebrospinal fluid and quicker than repeated imaging techniques. The biomarkers are based on the cell cycle hypothesis of AD, and were invented by Dr. Zsuzsanna Nagy at The University of Oxford and the University of Birmingham.
The new funding will be used to advance commercialisation of the company's testing services for AD and MCI.
More on Early-stage
Sidekick spinoffs: Insurtech scale-ups attract PE interest
Investment set to break EUR 1.1bn mark this year as sponsors seek for rising stars
World Fund leads EUR 128m raise for quantum computing group IQM
Series-A2 for Finnish startup focused on combating the climate crisis also backed by the EIB
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater